Revolution Medicines, Inc. is 30.7x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($30.65 B vs $1.00 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGEM | RVMD |
|---|---|---|
| Market cap | $1.00 B | $30.65 B |
| US-listed rank | #2637 | #454 |
| Revenue (latest FY) | $0.00 | $0.00 |
| Net income (latest FY) | -$219.88M | -$1.13B |
| SEC filings | 435 | 782 |
Revolution Medicines, Inc. is 30.7x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($30.65 B vs $1.00 B).
In their latest fiscal years, Cullinan Therapeutics, Inc. reported $0.00 in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Cullinan Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.